$PTLF PetLife Pharmaceuticals, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PetLife Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in PetLife Pharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in PetLife Pharmaceuticals, Inc. for free.
IRS Number: 331133537
Industry: INDUSTRIAL ORGANIC CHEMICALS [2860]
Trading Symbol: PTLF
Company Address: 8033 SUNSET BLVD, SUITE 867, LOS ANGELES, 90046
Phone number: 844-473-8543
Former name: AZTEK VENTURES INC., date of change: 2006-02-27
Former name: GENESIS URANIUM CORP., date of change: 2007-11-13
Former name: Vault Technology, Inc., date of change: 2008-05-07
Former name: Modern Renewable Technologies, Inc., date of change: 2010-01-14
Former name: ECO VENTURES GROUP, INC., date of change: 2011-06-02
Market Capitalization: $9.55M
Prev close: $0.16
Average Daily Volume: 22,211
Days Low: $0.16
Year Low: $0.08
Year High: $1.00
PetLife Pharmaceuticals, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 20 2018 | PTLF | PetLife Pharmaceut ... | Campbell Vyvyan | Director | Buy | P | 4,017.00 | 305,000 | 1,225,185,000 | 1,305,000 | 1000 K to 1.3 M (+30.50 %) |
| Mar 02 2018 | PTLF | PetLife Pharmaceut ... | Salvagno Ralph T | Chief Executive Off ... | Grant | A | 0.06 | 5,000,000 | 300,000 | 17,450,000 | 12.5 M to 17.5 M (+40.16 %) |
| Mar 02 2018 | PTLF | PetLife Pharmaceut ... | Salvagno Ralph T | Chief Executive Off ... | Buy | J | 0.00 | 1,250,000 | 0 | 1,250,000 | 0 to 1.3 M |
| Mar 02 2018 | PTLF | PetLife Pharmaceut ... | Salvagno Ralph T | Chief Executive Off ... | Sell | J | 0.00 | 1,250,000 | 0 | 12,450,000 | 13.7 M to 12.5 M (-9.12 %) |
| Mar 02 2018 | PTLF | PetLife Pharmaceut ... | Campbell Vyvyan | Director | Buy | J | 0.00 | 1,000,000 | 0 | 1,000,000 | 0 to 1000 K |
| Mar 02 2018 | PTLF | PetLife Pharmaceut ... | Campbell Vyvyan | Director | Sell | J | 0.00 | 1,000,000 | 0 | 1,000,000 | 2 M to 1000 K (-50.00 %) |
| Mar 02 2018 | PTLF | PetLife Pharmaceut ... | Vivek Ramana | Chief Medical Offic ... | Buy | J | 0.00 | 1,000,000 | 0 | 1,000,000 | 0 to 1000 K |
| Mar 02 2018 | PTLF | PetLife Pharmaceut ... | Vivek Ramana | Chief Medical Offic ... | Sell | J | 0.00 | 1,000,000 | 0 | 1,000,000 | 2 M to 1000 K (-50.00 %) |
| Mar 02 2018 | PTLF | PetLife Pharmaceut ... | Vivek Ramana | Chief Medical Offic ... | Grant | A | 0.67 | 1,000,000 | 670,000 | 2,000,000 | 1000 K to 2 M (+100.00 %) |
| Mar 27 2017 | PTLF | PetLife Pharmaceut ... | Salvagno Ralph T | CEO | Option Exercise | A | 0.25 | 2,000,000 | 500,000 | 2,000,000 | |
| Mar 27 2017 | PTLF | PetLife Pharmaceut ... | Salvagno Ralph T | CEO | Grant | A | 0.50 | 11,160,000 | 5,580,000 | 12,300,000 | 1.1 M to 12.3 M (+978.95 %) |
| Mar 27 2017 | PTLF | PetLife Pharmaceut ... | Salvagno Ralph T | CEO | Buy | P | 0.64 | 250,000 | 160,000 | 1,140,000 | 890 K to 1.1 M (+28.09 %) |
| Mar 27 2017 | PTLF | PetLife Pharmaceut ... | Salvagno Ralph T | CEO | Buy | P | 0.46 | 540,000 | 248,400 | 890,000 | 350 K to 890 K (+154.29 %) |
| Mar 27 2017 | PTLF | PetLife Pharmaceut ... | Salvagno Ralph T | CEO | Buy | P | 0.64 | 250,000 | 160,000 | 350,000 | 100 K to 350 K (+250.00 %) |
| Mar 27 2017 | PTLF | PetLife Pharmaceut ... | Salvagno Ralph T | CEO | Buy | P | 0.25 | 100,000 | 25,000 | 100,000 | 0 to 100 K |
View all PetLife Pharmaceuticals, Inc. insider transactions.